300497.SZ
富祥股份
SZSE · Healthcare · C 制造业 · CN
CNY 17.02
−1.45%Price chart
Aug 6Aug 11Aug 14Aug 19Aug 24Aug 27Sep 1Sep 4
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
88.3x
Market Cap
CNY 9.17B
MomentumView details →
1D Return
−1.45%
YTD Return
+20.98%
RSI (14)
55.3
ValuationView details →
P/E (Fwd)
—
EV/EBITDA
88.3x
Market Cap
CNY 9.17B
RSI (14)
55.3
MomentumView details →
1D Return
−1.45%
YTD Return
+20.98%
Similar companies
Latest newsMore news →
Fuxiang Co., Ltd. reported H1 2026 revenue of 888 million yuan, up 72.59% year-on-year, and net profit of 177 million yuan, turning from loss to profit, driven by price increases and capacity expansion in electrolyte additives.22d agoFuxiang Co., Ltd. announced an interim dividend for the first half of 2026 of 0.5 yuan per 10 shares, totaling 26.93 million yuan, approved by the board on August 10.24d agoFushun Co., Ltd.'s chairman proposed a 2026 interim dividend plan of 0.5 yuan per 10 shares.44d ago